GSTM1 and Familial prostate cancer: Positing tumor metabolomic microenvironments to be sensitive to prostate cancer characteristics, we investigated the clinical potential of tissue magnetic resonance spectroscopy (MRS) analysis of human histologically-benign (Hb; no histologically identifiable prostate cancer cells or glands) samples that were obtained from cancerous prostates.